So - PRR is in trading halt pending an announcement regarding news from the FDA.
I don't know much at all about FDA processes.
What news do we expect? Is it essentially around the FDA giving a nod of approval to a particular trial design? Particularly around the number of patients to be trialled? And therefore the cost to PRR of completing such a trial?
If so - what would people on this thread consider to be "good" news? What parameters will you be focused on? What would represent "good" news on these parameters??
I look forward to your thoughts.
So - PRR is in trading halt pending an announcement regarding...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $566.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.5¢ | $997.5K | 2.559M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 85852 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 75389 | 4 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |